A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C

✍ Scribed by Antonio Ojea; José Luís Nogueira; Eduardo Solsona; Nicolás Flores; Jesús María Fernández Gómez; Jesús Rodríguez Molina; Venancio Chantada; José Emilio Camacho; Luís Martínez Piñeiro; Rafael Hernandez Rodríguez; Santiago Isorna; Miguel Blas; José A. Martínez-Piñeiro; Rosario Madero

• Book ID: 113610084
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 250 KB
• Volume: 52
• Category: Article
• ISSN: 0302-2838
• DOI: 10.1016/j.eururo.2007.04.062